Search
These data provide evidence that otitis-prone children do not have impaired functional cell mediated immunity
This Clinical Puzzle article describes our current knowledge of chronic otitis media and the existing research models for this condition
The production of functional antipneumococcal antibodies in otitisprone children demonstrates that they respond to the current pneumococcal conjugate vaccine (PCV)and are likely to respond to pneumolysin-based vaccines as effectively as healthy children.
Our findings are in line with a number of epidemiological studies which show a positive association between breastfeeding and OM in early childhood
Conserved vaccine candidate proteins from S.pneumoniae induce serum and salivary antibody responses in Aboriginal and non-Aboriginal children with history of OM
Identified dominant PCR-ribotypes common to geographically disparate Australian paediatric populations
As Head of Aboriginal Research Development at Telethon Kids, Glenn Pearson believes his work brings us closer to identifying the real and whole Australian story
Research projects sharing in a $2.1 million funding boost will seek to translate research findings into changes that benefit patients and help the health system run more efficiently.
To assess the degree to which timely audiological assessment of congenital hearing loss is achieved at our institution - Perth Children's Hospital, Western Australia, and to review cases which breached this timeframe in order to address barriers to timely assessment. The benchmark used to determine timely assessment is that set out by The Joint Committee on Infant Hearing (JCIH) in which diagnostic audiological testing occurs by three months of age for those who do not pass newborn hearing screening.
Our goal was to identify genetic risk factors for severe otitis media (OM) in Aboriginal Australians.